» Articles » PMID: 8944736

Nonsteroidal Anti-inflammatory Drugs and the Risk of Hospitalization for Acute Renal Failure

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 1996 Nov 25
PMID 8944736
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Few studies have evaluated the association between use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of idiopathic acute renal failure (ARF) in the general population.

Methods: Population-based case-control study among persons in the Canadian province of Saskatchewan who received at least 1 NSAID prescription between January 1, 1982, and December 31, 1986. Health department databases were used for case detection, as the sampling frame for selecting controls (n = 1997), and as the primary source of information on drug use and comorbidity. A total of 306 hospital records were reviewed. Twenty-eight patients who were hospitalized fulfilled the diagnostic criteria for ARF.

Results: The incidence rate of hospitalization for ARF among the general population not exposed to NSAIDs was 2 per 100000 person-years. Current exposure to NSAIDs, acetylsalicylic acid and other nephrotoxic drugs, male gender, increasing age, cardiovascular comorbidity, and recent hospitalization for disorders other than renal were found to be independent risk factors for ARF. Current NSAID users had an adjusted odds ratio for ARF of 4.1 (95% confidence interval, 1.5-10.8). The risk of ARF was especially high during the first month of use (odds ratio, 8.5). For prescribed dose, we found that users of high daily doses of NSAIDs experienced an odds ratio of 9.8 for ARF.

Conclusions: In the general population, hospitalizations for ARF were found to be a rare condition. The 4-fold increase in risk associated with NSAID use was dose-dependent and occurred especially during the first month of therapy. Concurrent comedication with other potentially nephrotoxic agents should be prescribed with care, especially in the elderly.

Citing Articles

Acute Kidney Injury in Hospitalized Patients With Exertional Rhabdomyolysis.

Sabouri A, Yurgionas B, Khorasani S, Durant E, Kafaie J, Hung Y JAMA Netw Open. 2024; 7(8):e2427464.

PMID: 39136944 PMC: 11322840. DOI: 10.1001/jamanetworkopen.2024.27464.


A Randomized Placebo-Controlled Trial of Efficacy and Safety: Drug-Free Gel Containing Ultra-Deformable Phospholipid Vesicles (TDT 064) in Osteoarthritic Knees.

Yuenyongviwat V, Iamthanaporn K, Tuntarattanapong P, Hongnaparak T, Tangtrakulwanich B Clin Med Insights Arthritis Musculoskelet Disord. 2021; 14:11795441211031338.

PMID: 34377044 PMC: 8326992. DOI: 10.1177/11795441211031338.


Toxicological Evaluation of Novel Cyclohexenone Derivative in an Animal Model through Histopathological and Biochemical Techniques.

Kamil M, Fatima A, Ullah S, Ali G, Khan R, Ismail N Toxics. 2021; 9(6).

PMID: 34070633 PMC: 8227666. DOI: 10.3390/toxics9060119.


Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.

Jones P, Lamdin R, Dalziel S Cochrane Database Syst Rev. 2020; 8:CD007789.

PMID: 32797734 PMC: 7438775. DOI: 10.1002/14651858.CD007789.pub3.


Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza.

Lund L, Reilev M, Hallas J, Kristensen K, Thomsen R, Christiansen C JAMA Netw Open. 2020; 3(7):e2013880.

PMID: 32609352 PMC: 7330719. DOI: 10.1001/jamanetworkopen.2020.13880.